Adtalem Global Education (NYSE:CVSA) Insider Karen Sue Cox Sells 2,000 Shares

Adtalem Global Education Inc. (NYSE:CVSA) insider Karen Sue Cox sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $124.50, for a total value of $249,000.00. Following the sale, the insider directly owned 31,596 shares of the company’s stock, valued at $3,933,702. The trade was a 5.95% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 1.5%

Shares of NYSE:CVSA opened at $128.28 on Wednesday. The firm has a market cap of $4.37 billion, a P/E ratio of 19.98, a price-to-earnings-growth ratio of 1.08 and a beta of 0.63. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The business’s 50-day simple moving average is $112.44. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last released its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million during the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The business’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities research analysts predict that Adtalem Global Education Inc. will post 8.03 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CVSA. Weiss Ratings began coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Wall Street Zen downgraded Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday. Truist Financial lifted their target price on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Friday, April 17th. Finally, Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.